• CART peptide inhibited cocaine-mediated locomotion after single cocaine injection.
Introduction
The nucleus accumbens (NAc) is part of the reward pathway of the brain and is a major mediator of cocaine-induced behavioral effects including cocaine self-administration and cocaine-induced locomotor activity (LMA). Cocaine-induced behaviors are sensitive to changes in the concentration of cocaine-and-amphetamine regulated transcript (CART) peptide in the NAc [12] [13] [14] . An injection of CART 55-102 into the NAc blunts the effects of acute administration of cocaine and dopamine (DA) [13] . Conversely, depletion of endogenous CART peptide in the NAc results in a potentiation of cocaine-induced LMA [14] . There is an enhanced expression of CART in the NAc of human cocaine abusers [1, 3] . Cocaine enhances CART expression in the NAc of animals [5, 7, 9, 11] . Because of these findings, it has been postulated that CART peptide is a homeostatic regulator of DA-and cocaine-induced actions in the NAc [13, 23] .
Repeated administration of cocaine can induce persistent alterations in the structure and function of the NAc (a) shortly after the last cocaine administration and (b) several weeks after withdrawal from repeated cocaine administration [2, 6, 8, [16] [17] [18] 24, 28] . For instance, chronic intermittent administration of cocaine led to a lowering of basal DA levels in the NAc [22] . Also, repeated daily injections of cocaine (10 mg/kg, i.p.) for 15 days resulted in a significant increase in the number of DA D2 receptor (D2R) binding sites [8, 17] and a decrease [17] in the number of DA D1 receptor (D1R) binding sites in the NAc shortly after cessation of cocaine administration, but these changes were absent 2 weeks after halting the cocaine administration. Furthermore, chronic cocaine exposure increased the density of dendritic spines in the NAc shell shortly after chronic cocaine administration but there was a return to baseline 4 weeks after cocaine withdrawal. In the NAc core on the other hand, spines were unchanged shortly after repeated cocaine administration but were persistently decreased 4 weeks after withdrawal [6] . These findings suggest that there are dynamic changes in the NAc after cocaine administration that presumably contribute to the addictive effect of cocaine.
Repeated intravenous administration of cocaine down regulates DA D3 receptors in the NAc [25] and DA D3 receptors D3R regulate CART mRNA in the NAc [4, 10] . Furthermore, CART peptide attenuates the effect of combined, acute DA D1-D2 receptor activation [19] , but repeated cocaine treatment causes a dysregulation of DA D1-D2 dopamine receptor signaling [2] . With these structural and functional changes in the NAc (a) shortly after chronic administration of cocaine and (b) after withdrawal from repeated administration of cocaine, it is important to determine if there are corresponding changes in the effect of CART peptide on cocainemediated effects. In this study, we looked at the effect of CART peptide on LMA after acute and chronic administration of cocaine and after withdrawal from chronic cocaine treatments.
Materials and methods
A total of 41 male Sprague Dawley rats (Charles River Inc., Wilmington, MA), weighing 386-542 g during locomotor activity (LMA) experiments were used. They were provided rat chow and water ad libitum, and maintained on a 12 h light:dark cycle (lights on at 7 am). Experiments and animal care were in accordance with the Institute of Animal Care and Use Committee of Emory University and the National Institutes of Health Guide for the Care and Use of Laboratory Animals. The rats were implanted, under isoflurane anesthesia, with bilateral stainless steel guide cannulae assembly (22 gauge; Plastics One; Roanoke, VA) using the following coordinates for the shell-core border of the nucleus accumbens: A/P 1.6 mm, L/M ± 1.5 mm, D/V −5.7 mm [21] . The experiments were designed to determine the effect of CART 55-102 on cocainemediated LMA -(a) after single cocaine injection, (b) after chronic cocaine injection, (c) 3 weeks after chronic cocaine and (d) 9 weeks after chronic cocaine.
On experiment day, rats were placed into locomotor chambers for 30 min to habituate to their surroundings before the recording of basal LMA commenced. After 30 min of basal LMA recording, rats were removed from the chambers, infused with saline (0.5 L/side) or CART 55-102 (2.5 g in 0.5 L of saline/side) immediately before an i.p. injection of an equivalent volume of saline (1 mL/kg) or cocaine (10 mg/kg), and placed back into the chambers for 60 min of additional LMA recording. The selected dose of CART peptide (2.5 g) and the selected dose of cocaine (10 mg/kg i.p.) were used because of their effectiveness in previous studies [13] . The chronic cocaine (or saline) regimen proceeded every day after the above experiment and involved administration of i.p. cocaine (10 mg/kg) (or saline) to rats once daily. On the 14th day, like the 1st day, cocaine-mediated LMA was measured. The rats that received saline infusion into the NAc before chronic cocaine (or chronic saline) received CART 55-102 after chronic cocaine (or chronic saline), and vice versa in a counterbalanced design. There were no significant differences in the body weights between the acute and chronic administration groups. For some animals, the experiment continued for up to 9 weeks after cessation of chronic cocaine administration. For these animals, each rat received both saline and CART 55-102 infusions into the NAc plus i.p. cocaine in two experimental days separated by at least 72 h apart (counterbalanced design) and LMA was measured.
On experiment days, intra-accumbal infusions were done using stainless steel bilateral injector cannulae (28 gauge, Plastics One), connected via polyethylene-50 (PE-50) tubing to two 25 L microsyringes (Hamilton Co, Reno, NV). The two microsyringes were driven by pumps connected to Micro4 Microsyringe Pump Controller (World Precision Instruments, Sarasota, FL). Fluid was bilaterally injected (0.5 L/side) for 30 s. The injected fluid was allowed to diffuse for an additional 30 s before removal of the injector cannluae. LMA was measured in 10 min intervals using a photocell cage (Omnitech Electronics, Columbus, OH) with transparent plexiglass walls (40 cm × 40 cm × 30 cm), containing 32 photobeams located 5 cm above the floor to record LMA. Each cage was placed in a stainless steel box and connected to a computer equipped with software (Digipro; Omnitech Electronics) to measure LMA.
After completion of the experiments, animals received an overdose of Ketamine (70 mg/kg) and dexmedetomidine (0.5 mg/kg), and were then perfused intracardially with saline and 4% paraformaldehyde in saline. After removal from the skull, brains were placed in 4% paraformaldehyde overnight, followed by immersion in 30% sucrose for several days and sliced (60 m slices) using a cryostat (Leica CM1900, Leica CM3050S, Leica Microsystems, Germany). Nissl staining was performed to further confirm placement of the injector tips. A stereotaxic brain atlas was used to approximate the placement of the injector tips.
Data are all expressed as mean ± SEM, and significance occurs when p < 0.05. All analyses were performed using GraphPad Prism version 5.00 for Windows (GraphPad Software, San Diego California USA, www.graphpad.com). LMA data were acquired in 10-min bins and time course data and total locomotor activity data were analyzed. For analysis of the time course data, a 2-way Repeated Measures ANOVA with Bonferroni post-test was used to check if there were main effects of treatment groups (between subjects), time (within subjects) and a treatment groups × time interaction. For time course data, the factors were treatment groups (4 levels: saline + saline, CART + saline, saline + cocaine, CART + cocaine) and time (9 levels). LMA data were also analyzed as total locomotor activity in 60 min -a summation of individual locomotor activity values for 60 min post-injection. For analysis of the total locomotor activity data, a 2-way ANOVA with Bonferroni post-test was used. For the total LMA data, the factors were treatment groups (4 levels) and chronic cocaine (2 levels: before and after). For analysis comparing LMA data before and after chronic cocaine administration, a 2-way ANOVA with Bonferroni post-test was used. Here, the factors were treatment groups (2 levels: saline + cocaine, CART + cocaine) and chronic cocaine (4 levels: before, at, 3 weeks after, at 9 weeks after).
Results
Rats received injections into the NAc of either saline alone or CART 55-102 alone, which was then immediately followed with an i.p. injection of either saline or cocaine, and LMA was measured. Measurements were made after one or 14 daily injections of cocaine (10 mg/kg) or saline. When the individual time points of LMA were analyzed separately (Fig. 1) or combined (total LMA) (Fig. 2 ), significant differences were found. Cocaine increased total LMA as expected, and CART 55-102 reduced cocaine-induced LMA as expected (Figs. 1 and 2 ) after a single injection of cocaine (on day 1). However, on day 14, after the repeated daily cocaine administration regimen, cocaine increased LMA as expected, but CART 55-102 had no effect on cocaine-induced LMA (Figs. 1 and 2) . Furthermore, CART 55-102 did not reduce cocaine-induced LMA at 3 or 9 weeks after withdrawal from the chronic cocaine administration (Fig. 3) . Thus, the loss of the inhibitory effect of CART 55-102 was long-lasting. The locations of the injections into the NAc were determined as described in Methods and as expected they were found throughout the extent of the NAc (Fig. 4) .
Discussion
CART peptide attenuated cocaine-induced LMA after acute administration of cocaine, but this effect was lost after repeated (14 days) cocaine administration. Also, the CART peptide inhibitory effect on cocaine-induced LMA did not return even after 9 weeks of withdrawal from repeated cocaine administration. Our study confirms the effect of intra-NAc CART peptide on acute cocaine administration [13] , and shows for the first time that the inhibitory effect of CART peptide is lost after repeated, non-contingent cocaine The data is a summation of the time points after cocaine (coc) administration in Fig. 1 . The rats that received CART on day 1 received saline on day 14, and vice versa. The y-axis represents total distance covered in 60 min after cocaine (or saline) injection. 2-way ANOVA showed a significant treatment effect (F3, 70 = 12.58, ***p < 0.0001), an almost significant chronic coc effect (F1, 70 = 2.974, p = 0.0890) and an interaction (F3, 70 = 3.052, *p = 0.0341). Bonferroni post hoc tests showed that CART + coc was significantly different from saline + coc on day 1 but was not different after chronic cocaine administration. Bonferroni post hoc tests also showed that the effect of CART + coc was significantly different after chronic coc administration. The p-values *p < 0.05, **p < 0.01, ***p < 0.001 show difference when comparing all groups to saline + saline. The p-values # p < 0.05, ## p < 0.01, ### p < 0.001 show difference when comparing between saline + coc and CART + coc groups. The p-values + p < 0.05, ++ p < 0.01, +++ p < 0.001 show the difference when comparing treatments between day 1 (before chronic cocaine) and day 14 (after chronic cocaine). The significant differences after post hoc analysis are shown in the graph. CART 55-102 (2.5 g) or saline was administered directly into the NAc of male rats immediately before an i.p. injection of saline or cocaine (coc) (10 mg/kg) acutely (day 1), after additional 13 days (day 14) of cocaine (10 mg/kg) administration once daily and at different time points after withdrawal of chronic administration of cocaine-10 mg/kg and LMA was measured. The groups were as follows (before chronic coc administration) [saline + coc (n = 15), CART + coc (n = 15)], (after chronic coc administration) [saline + coc (n = 13), CART + coc (n = 13)] (3 weeks after chronic coc administration) [saline + coc (n = 10), CART + coc (n = 10)], and (9 weeks after chronic coc administration) [saline + coc (n = 7), CART + coc (n = 8)]. The y-axis represents distance covered in 60 min after cocaine injection. The x-axis represents the conditions relative to chronic coc administration. 2-way ANOVA showed no significant treatment effect (F1, 83 = 0.03841, p = 0.8451), a significant difference between conditions relative to time before chronic coc (F3, 83 = 5.199, **p = 0.0024) and no interaction (F3, 83 = 1.931, p = 0.1309). Bonferroni post hoc tests showed that the effect of CART + coc before chronic coc was significantly different from its effect after chronic coc and even after allowing rat to recover for up to 9 weeks after chronic coc. The p-values *p < 0.05, **p < 0.01, ***p < 0.001 show difference when comparing treatment groups between all conditions relative to chronic coc. The significant differences after post hoc analysis are shown in the graph. administration. Our results are supported by a study showing that 3 weeks after withdrawal from chronic cocaine regimen (15 mg/kg i.p. x 7 days), intra-NAc infusion of CART 55-102 (2.5 g) inhibited locomotor sensitization but not locomotor activity per se after cocaine (10 mg/kg i.p.) administration [26] . Our data implies that chronic cocaine persistently altered the CART peptide system in the NAc. Other systems in the NAc that are similarly dysregulated by chronic cocaine include the Orexin [27] and Dynorphin A [20] systems, with alterations persisting even beyond 2 months after cessation of repeated cocaine [27] .
Cocaine-induced LMA is due to DA effect in the NAc and CART peptide attenuates acute DA-mediated LMA by suppressing the effect of a combined activation of D1R and D2R [13, 19] . After chronic cocaine administration in a similar experimental design (cocaine 10 mg/kg i.p. × 15 days), D1R were transiently reduced in the NAc while D2R were increased in the NAc [17] . Given that CART peptide attenuates the LMA of a combined D1R and D2R activation, the change in D1R to D2R ratio or effect in the NAc shortly after chronic administration of cocaine may be at least part of the mechanism of the effects of CART peptide (or lack of) in our study. Another possible mechanism of our results is that CART peptide is still effective but requires much higher doses to produce an effect. This could not be tested because higher doses of CART 55-102 tend to produce convulsions [15] . In any case, this would still be a cocaine-induced dysfunction of the CART peptide system in the NAc.
In conclusion, CART peptide attenuated cocaine-induced LMA after acute administration of cocaine as expected, but the inhibitory effect was lost after repeated cocaine administration and the CART peptide effect did not return even after 9 weeks of withdrawal from repeated cocaine administration. It is important to note that the studies herein are limited to LMA, and that studies with selfadministration or conditioned place preference are needed as well to fully conclude that such a loss of an inhibitory system after repeated cocaine administration may be a mechanism underlying the state of addiction.
